Common Bacteriostatic and Bactericidal Antibiotics
The traditional classification of antibiotics into bacteriostatic versus bactericidal categories has limited clinical relevance in most infections, as clinical outcomes (cure rates and mortality) are equivalent between these classes for pneumonia, skin/soft tissue infections, and intra-abdominal infections. 1, 2
Bactericidal Antibiotics (Kill Bacteria)
Beta-Lactams
- Penicillins: Ampicillin, piperacillin, amoxicillin-clavulanate, piperacillin-tazobactam 3, 4
- Cephalosporins: Cefazolin, cefuroxime, ceftriaxone, cefotaxime, ceftazidime, cefepime 5, 3
- Carbapenems: Meropenem, imipenem, doripenem, ertapenem 5
Aminoglycosides
- Gentamicin, tobramycin, amikacin - provide synergistic bactericidal activity when combined with beta-lactams 3
Fluoroquinolones
Glycopeptides
- Vancomycin 5
Nitroimidazoles
- Metronidazole (bactericidal against anaerobes, particularly Bacteroides fragilis) 6
Bacteriostatic Antibiotics (Inhibit Bacterial Growth)
Lincosamides
- Clindamycin - provides critical toxin suppression in necrotizing infections despite being bacteriostatic 4
Oxazolidinones
- Linezolid - clinically non-inferior to bactericidal agents in pneumonia, intra-abdominal infections, and skin/soft tissue infections 1, 2
Glycylcyclines
- Tigecycline - effective for severe infections despite bacteriostatic mechanism, though associated with slightly increased mortality in meta-analysis 2
Tetracyclines
- Tetracycline, doxycycline 7
Amphenicols
- Chloramphenicol - bactericidal at clinically achievable concentrations against H. influenzae, S. pneumoniae, and N. meningitidis, but bacteriostatic against gram-negative bacilli and S. aureus 7
Critical Clinical Context
The bactericidal versus bacteriostatic distinction only applies under strict laboratory conditions and is inconsistent for particular agents against different bacteria. 8
When Bactericidal Activity May Matter
- Endocarditis: Traditionally requires bactericidal therapy, though bacteriostatic agents like linezolid have been used successfully as salvage therapy 1, 8
- Meningitis: Bactericidal activity in cerebrospinal fluid is important due to inefficient leukocytic phagocytosis in the subarachnoid space 7
- Neutropenic fever: Bactericidal combinations (e.g., ceftazidime plus amikacin) are preferred 3
When Bacteriostatic Agents Are Adequate
- Pneumonia: No difference in clinical cure rates or mortality between bacteriostatic and bactericidal agents 2
- Skin and soft tissue infections: Bacteriostatic agents like linezolid and clindamycin are clinically equivalent or superior 1, 2
- Intra-abdominal infections: No clinical outcome difference between classes 2
Combination Therapy Considerations
The dogma against combining bacteriostatic and bactericidal agents is not supported by clinical evidence - many combinations show additive or synergistic effects rather than antagonism. 1, 9
Effective Combinations
- Linezolid plus rifampicin: Already used clinically without antagonism 1
- Piperacillin-tazobactam plus clindamycin: First-line for necrotizing soft tissue infections 4
- Penicillin/cephalothin plus tetracycline: Shows additive or synergistic activity in 40-50% of tested strains 9
Synergistic Bactericidal Combinations
- Ampicillin plus gentamicin: Synergistic against enterococci in endocarditis 3
- Beta-lactam plus aminoglycoside: Provides synergistic bactericidal activity for severe gram-negative infections 3
Key Pitfalls
- Avoid prolonged metronidazole courses due to risk of cumulative and potentially irreversible neurotoxicity 6
- Monitor aminoglycosides closely with renal function checks and limit duration to minimize nephrotoxicity and ototoxicity 3
- Do not assume bactericidal superiority - clinical outcomes guide therapy, not in vitro classifications 8
- Check clindamycin susceptibility and perform D-test for inducible resistance before relying on it for MRSA coverage 4